| Literature DB >> 33264090 |
Kirsteen M Tullett1, Peck Szee Tan1, Hae-Young Park1, Ralf B Schittenhelm2, Nicole Michael1, Rong Li3, Antonia N Policheni4,5, Emily Gruber1, Cheng Huang2, Alex J Fulcher6, Jillian C Danne7, Peter E Czabotar4,5, Linda M Wakim8, Justine D Mintern9, Georg Ramm1,7, Kristen J Radford10, Irina Caminschi1,8, Meredith O'Keeffe1, Jose A Villadangos8,9, Mark D Wright11, Marnie E Blewitt4,5, William R Heath8, Ken Shortman4,5, Anthony W Purcell1, Nicos A Nicola4,5, Jian-Guo Zhang4,5, Mireille H Lahoud1.
Abstract
The dendritic cell receptor Clec9A facilitates processing of dead cell-derived antigens for cross-presentation and the induction of effective CD8+ T cell immune responses. Here, we show that this process is regulated by E3 ubiquitin ligase RNF41 and define a new ubiquitin-mediated mechanism for regulation of Clec9A, reflecting the unique properties of Clec9A as a receptor specialized for delivery of antigens for cross-presentation. We reveal RNF41 is a negative regulator of Clec9A and the cross-presentation of dead cell-derived antigens by mouse dendritic cells. Intriguingly, RNF41 regulates the downstream fate of Clec9A by directly binding and ubiquitinating the extracellular domains of Clec9A. At steady-state, RNF41 ubiquitination of Clec9A facilitates interactions with ER-associated proteins and degradation machinery to control Clec9A levels. However, Clec9A interactions are altered following dead cell uptake to favor antigen presentation. These findings provide important insights into antigen cross-presentation and have implications for development of approaches to modulate immune responses.Entities:
Keywords: DAMP recognition; E3 ubiquitin ligase; antigen presentation; dendritic cells; immunology; inflammation; mouse; ubiquitination
Mesh:
Substances:
Year: 2020 PMID: 33264090 PMCID: PMC7710356 DOI: 10.7554/eLife.63452
Source DB: PubMed Journal: Elife ISSN: 2050-084X Impact factor: 8.140